Vitamin-B3 derivative may cut risk of new skin cancers by 23%


cancer explained
New research indicates taking an oral vitamin-B3 derivative, nicotinamide, may help prevent the recurrence of non-melanoma skin cancers. According to new Australian research, the ONTRAC study, published today in the New England Journal of Medicine, taking an oral vitamin-B3 derivative, nicotinamide, may help prevent non-melanoma skin cancers (NMSCs) in high risk patients. The randomised placebo

This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous US pharmacy praised for dispensing monster repellent
Next SanFilippo Children's Foundation: shave to save sick kids